Julia is a founding partner of Interface Fund, an early stage deep tech venture capital supporting innovation at the intersection of physics and biology. Prior to Interface Fund, Julia co-founded healthcare startup Igantia Therapeutics (UCSF spin-off, acquired in 2019$ and was a partner at Mindrock Capital, a grow stage venture fund from San Francisco